Semler Scientific (NASDAQ:SMLR – Get Free Report) and Viveve Medical (NASDAQ:VIVE – Get Free Report) are both medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their earnings, profitability, analyst recommendations, dividends, institutional ownership, valuation and risk.
Volatility and Risk
Semler Scientific has a beta of 0.92, indicating that its share price is 8% less volatile than the S&P 500. Comparatively, Viveve Medical has a beta of 0.51, indicating that its share price is 49% less volatile than the S&P 500.
Analyst Ratings
This is a breakdown of recent ratings and price targets for Semler Scientific and Viveve Medical, as reported by MarketBeat.com.
Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
Semler Scientific | 0 | 0 | 0 | 1 | 4.00 |
Viveve Medical | 0 | 0 | 0 | 0 | 0.00 |
Institutional and Insider Ownership
49.4% of Semler Scientific shares are held by institutional investors. 30.2% of Semler Scientific shares are held by insiders. Comparatively, 5.7% of Viveve Medical shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.
Valuation & Earnings
This table compares Semler Scientific and Viveve Medical”s revenue, earnings per share (EPS) and valuation.
Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
Semler Scientific | $68.18 million | 5.07 | $20.58 million | $2.05 | 23.19 |
Viveve Medical | $6.43 million | N/A | -$22.03 million | N/A | N/A |
Semler Scientific has higher revenue and earnings than Viveve Medical.
Profitability
This table compares Semler Scientific and Viveve Medical’s net margins, return on equity and return on assets.
Net Margins | Return on Equity | Return on Assets | |
Semler Scientific | 27.00% | 20.31% | 18.78% |
Viveve Medical | N/A | N/A | N/A |
Summary
Semler Scientific beats Viveve Medical on 10 of the 10 factors compared between the two stocks.
About Semler Scientific
Semler Scientific, Inc. provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company’s products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient’s vascular condition. It also offers Insulin Insights, a software program that is used by a healthcare provider to optimize outpatient insulin dosing. The company’s products serve cardiologists, internists, nephrologists, endocrinologists, podiatrists, family practitioners, healthcare insurance plans, integrated delivery networks, independent physician groups, and companies contracting with the healthcare industry, such as risk assessment groups and retailers. It offers its products through sales representatives and distributors. The company was incorporated in 2007 and is headquartered in Santa Clara, California.
About Viveve Medical
Viveve Medical, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices for the non-invasive treatment of vaginal introital laxity, sexual function, vaginal rejuvenation, and stress urinary incontinence. The company offers Viveve System comprises of the radiofrequency generator, reusable handpiece, and treatment tip, as well as cryogen canister and other consumable components. It markets its products through sales employees and distributors in the United States, Canada, the Asia Pacific, Europe, the Middle East, Latin America, and internationally. Viveve Medical, Inc. was founded in 2005 and is headquartered in Englewood, Colorado.
Receive News & Ratings for Semler Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Semler Scientific and related companies with MarketBeat.com's FREE daily email newsletter.